| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria. | Blood | 2011 | 1.68 |
| 2 | A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa. | J Invest Dermatol | 2010 | 1.61 |
| 3 | Hypoxia-inducible factor-1alpha regulates the expression of nucleotide excision repair proteins in keratinocytes. | Nucleic Acids Res | 2009 | 0.88 |
| 4 | Report of a novel Indian case of congenital erythropoietic porphyria and overview of therapeutic options. | J Pediatr Hematol Oncol | 2013 | 0.75 |